D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 61 700 KRW -2.99% Market Closed
Market Cap: 553.9B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Dong-A ST Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dong-A ST Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Additional Paid In Capital
â‚©292.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Yuhan Corp
KRX:000100
Additional Paid In Capital
-â‚©93.7B
CAGR 3-Years
-6%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
SK Biopharmaceuticals Co Ltd
KRX:326030
Additional Paid In Capital
â‚©1.1T
CAGR 3-Years
0%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Additional Paid In Capital
â‚©368B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Additional Paid In Capital
â‚©99.8B
CAGR 3-Years
29%
CAGR 5-Years
43%
CAGR 10-Years
23%
C
Celltrion Pharm Inc
KOSDAQ:068760
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
530.5B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
95 195.66 KRW
Undervaluation 35%
Intrinsic Value
Price
D

See Also

What is Dong-A ST Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
292.4B KRW

Based on the financial report for Jun 30, 2024, Dong-A ST Co Ltd's Additional Paid In Capital amounts to 292.4B KRW.

What is Dong-A ST Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
3%

Over the last year, the Additional Paid In Capital growth was 2%. The average annual Additional Paid In Capital growth rates for Dong-A ST Co Ltd have been 1% over the past three years , and 3% over the past ten years .

Back to Top